Shanghai Universal BiotechLtd Management
Management criteria checks 3/4
Shanghai Universal BiotechLtd's CEO is Zhaowu Leng, appointed in Nov 2015, has a tenure of 9.08 years. directly owns 35.58% of the company’s shares, worth CN¥894.74M. The average tenure of the management team and the board of directors is 6.1 years and 4.7 years respectively.
Key information
Zhaowu Leng
Chief executive officer
CN¥1.9m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 9.1yrs |
| CEO ownership | 35.6% |
| Management average tenure | 6.1yrs |
| Board average tenure | 4.7yrs |
Recent management updates
Recent updates
We Think That There Are More Issues For Shanghai Universal BiotechLtd (SZSE:301166) Than Just Sluggish Earnings
Nov 05
Pinning Down Shanghai Universal Biotech Co.,Ltd.'s (SZSE:301166) P/S Is Difficult Right Now
Oct 15What Shanghai Universal Biotech Co.,Ltd.'s (SZSE:301166) 25% Share Price Gain Is Not Telling You
May 08Shanghai Universal BiotechLtd's (SZSE:301166) Sluggish Earnings Might Be Just The Beginning Of Its Problems
May 03CEO
Zhaowu Leng (54 yo)
9.1yrs
Tenure
CN¥1,857,400
Compensation
Mr. Zhaowu Leng has been the Chairman and General Manager of Shanghai Universal Biotech Co.,Ltd. since November 23, 2015.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 9.1yrs | CN¥1.86m | 35.58% CN¥ 894.7m | |
| CFO & Deputy GM | 5.3yrs | CN¥1.35m | no data | |
| Deputy GM & Director | 9.1yrs | CN¥1.09m | 10.41% CN¥ 261.9m | |
| Deputy GM & Director | 9.1yrs | CN¥1.23m | no data | |
| Board Secretary | 6.1yrs | CN¥892.30k | no data | |
| Deputy General Manager | 6.1yrs | CN¥939.00k | no data | |
| Deputy General Manager | 3.8yrs | CN¥927.10k | no data | |
| Deputy General Manager | 2.8yrs | CN¥1.33m | no data |
6.1yrs
Average Tenure
44yo
Average Age
Experienced Management: 301166's management team is seasoned and experienced (6.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 9.1yrs | CN¥1.86m | 35.58% CN¥ 894.7m | |
| Deputy GM & Director | 9.1yrs | CN¥1.09m | 10.41% CN¥ 261.9m | |
| Deputy GM & Director | 9.1yrs | CN¥1.23m | no data | |
| Board Secretary | 4.7yrs | CN¥892.30k | no data | |
| Supervisor | 4.7yrs | no data | no data | |
| Director | 9.1yrs | no data | no data | |
| Independent Director | 4.7yrs | CN¥80.00k | no data | |
| Independent Director | 4.7yrs | CN¥80.00k | no data | |
| Employee Representative Chairman of the Supervisory Board | 6.1yrs | no data | no data | |
| Employee Representative Supervisor | 2.9yrs | no data | no data | |
| Non-Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data |
4.7yrs
Average Tenure
45yo
Average Age
Experienced Board: 301166's board of directors are considered experienced (4.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 08:42 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai Universal Biotech Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|